CITIC Securities: Bullish on high-quality innovative pharmaceutical companies, focusing on cutting-edge technologies such as brain-machine interfaces.

Citic Securities Research Report stated that global liquidity is expected to continue to improve, and national policies encourage industrial innovation. It continues to be optimistic about high-quality innovative pharmaceutical companies with global competitiveness. At the same time, it is recommended to actively pay attention to cutting-edge technologies, such as innovative drugs, pharmaceuticals, and medical devices.